| Titolo |
Pubblicato in |
Anno |
| Sex-related differences in response to lomitapide in HoFH: A subanalysis of the Pan-European Lomitapide retrospective observational study |
ATHEROSCLEROSIS |
2025 |
| Sex Differences in Diagnosis, Treatment, and Cardiovascular Outcomes in Homozygous Familial Hypercholesterolemia |
JAMA CARDIOLOGY |
2024 |
| Genetic heterogeneity of familial hypercholesterolaemia in two populations from two different countries |
EUROPEAN JOURNAL OF INTERNAL MEDICINE |
2024 |
| Contemporary lipid-lowering management and risk of cardiovascular events in homozygous familial hypercholesterolaemia: insights from the Italian LIPIGEN Registry |
EUROPEAN JOURNAL OF PREVENTIVE CARDIOLOGY |
2024 |
| Is bempedoic acid a drug for female subjects? Preliminary analysis in an Italian cohort |
ATHEROSCLEROSIS |
2024 |
| Effect of Cholesterol-Lowering Variants in ANGPTL3 and APOB Genes on Liver Disease |
JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY |
2024 |
| Protocol for oil red O staining of low-density lipoproteins for in vivo cell treatment |
STAR PROTOCOLS |
2024 |
| How ANGPTL3 Inhibition Will Help Our Clinical Practice? |
CURRENT ATHEROSCLEROSIS REPORTS |
2023 |
| Long-term hepatic safety of lomitapide in homozygous familial hypercholesterolaemia. |
LIVER INTERNATIONAL |
2023 |
| Effectiveness of clinical scores in predicting coronary artery disease in familial hypercholesterolemia: a coronary computed tomography angiography study |
LA RADIOLOGIA MEDICA |
2023 |
| ANGPTL3 Deficiency and Risk of Hepatic Steatosis |
CIRCULATION |
2023 |
| Real‐World Effectiveness of PCSK9 Inhibitors in Reducing LDL‐C in Patients With Familial Hypercholesterolemia in Italy: A Retrospective Cohort Study Based on the AIFA Monitoring Registries |
JOURNAL OF THE AMERICAN HEART ASSOCIATION. CARDIOVASCULAR AND CEREBROVASCULAR DISEASE |
2023 |
| ANGPTL3 Deficiency and Risk of Hepatic Steatosis |
CIRCULATION |
2023 |
| Statin liver safety in non-alcoholic fatty liver disease: a systematic review and metanalysis |
BRITISH JOURNAL OF CLINICAL PHARMACOLOGY |
2022 |
| Worldwide experience of homozygous familial hypercholesterolaemia: retrospective cohort study |
THE LANCET |
2022 |
| Metabolic syndrome but not fatty liver-associated genetic variants correlates with glomerular renal function decline in patients with non-alcoholic fatty liver disease |
BIOMEDICINES |
2022 |
| The Fibrinogen-like Domain of ANGPTL3 Facilitates Lipolysis in 3T3-L1 Cells by Activating the Intracellular Erk Pathway |
BIOMOLECULES |
2022 |
| ANGPTL3 deficiency associates with the expansion of regulatory T cells with reduced lipid content |
ATHEROSCLEROSIS |
2022 |
| Efficacy of Long-Term Treatment of Autosomal Recessive Hypercholesterolemia With Lomitapide: A Subanalysis of the Pan-European Lomitapide Study |
FRONTIERS IN GENETICS |
2022 |
| Heterogeneity of non-alcoholic fatty liver disease (NAFLD): implication for cardiovascular risk stratification |
ATHEROSCLEROSIS |
2022 |
